15-HETE
|
Basic information |
| Metabolite name | 15-HETE |
 | HMDB0003876 |
 |
C04742 |
 |
5280724 |
| Synonyms | (±)15-HETE; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | 15-HETE |
| HMDB0003876 |
|
C04742 |
|
5280724 |
| Synonyms | (±)15-HETE; |
| No. of studies | 6 |
|
Relationship between 15-HETE and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1140 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M1140 | Type2 | CUMS + Chaihu Shugan San group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M1140 | Type2 | CUMS + Hypericum perforatum L. group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Up |
| Study M598 | Type1 | MS group vs. control group | Brain | Sprague-Dawley rat | Up |
| Study M784 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Up |
| Study M784 | Type2 | CUMS + liquiritin group vs. CUMS group | Brain | Sprague-Dawley rat | Down |
| Study M784 | Type2 | CUMS + fluoxetine group vs. CUMS group | Brain | Sprague-Dawley rat | Down |
| Study M867 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Brain | Sprague-Dawley rat | Down |
| Study M898 | Type1 | end-stage renal disease with depression group vs. end-stage renal disease without depression group | Serum | Human | Up |